Tricuspid regurgitation risk factors
|
Tricuspid Regurgitation Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Tricuspid regurgitation risk factors On the Web |
|
American Roentgen Ray Society Images of Tricuspid regurgitation risk factors |
|
Risk calculators and risk factors for Tricuspid regurgitation risk factors |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Basir Gill, M.B.B.S, M.D.[2]
Overview
Atrial fibrillation is a major risk factor for the development and progression of secondary tricuspid regurgitation and may act as both a causal and accelerative factor through atrial enlargement and annular dilation. Other common risk factors in the development of tricuspid regurgitation include infections, endocarditis, ebstein anomaly, tricuspid valve prolapse, carcinoid, papillary muscle dysfunction and medications. Most cases of significant tricuspid regurgitation are due to tricuspid annular dilation and leaflet tethering secondary to right ventricular remodeling from volume and/or pressure overload.
Risk Factors
Common Risk Factors
- Common risk factors in the development of tricuspid regurgitation include:[1][2][3][4]
- Atrial Fibrillation
- Rheumatic Heart Disease
- Endocarditis is a common risk factor in developing tricuspid regurgitation due to the following:
- Alcoholism
- Intravenous drug use
- Cardiac tumours
- Indwelling catheters which might get infected
- Burns when extensive
- Tricuspid valve prolapse
- Papillary muscle dysfunction
- RV dilatation
- Trauma which includes:
- Right ventricular endomyocardial biopsy
- Blunt chest wall trauma like stab wounds and projectiles
Less Common Risk Factors
- Less common risk factors in the development of tricuspid regurgitation include:
References
- ↑ Hahn RT (May 2023). "Tricuspid Regurgitation". N Engl J Med. 388 (20): 1876–1891. doi:10.1056/NEJMra2216709. PMID 37195943 Check
|pmid=value (help). - ↑ Mutlak D, Lessick J, Reisner SA, Aronson D, Dabbah S, Agmon Y (2007). "Echocardiography-based spectrum of severe tricuspid regurgitation: the frequency of apparently idiopathic tricuspid regurgitation". J Am Soc Echocardiogr. 20 (4): 405–8. doi:10.1016/j.echo.2006.09.013. PMID 17400120.
- ↑ Shah PM, Raney AA (2008). "Tricuspid valve disease". Curr Probl Cardiol. 33 (2): 47–84. doi:10.1016/j.cpcardiol.2007.10.004. PMID 18222317.
- ↑ Waller BF (1987). "Etiology of pure tricuspid regurgitation". Cardiovasc Clin. 17 (2): 53–95. PMID 3536106.
- ↑ Baseman DG, O'Suilleabhain PE, Reimold SC, Laskar SR, Baseman JG, Dewey RB (2004). "Pergolide use in Parkinson disease is associated with cardiac valve regurgitation". Neurology. 63 (2): 301–4. doi:10.1212/01.wnl.0000129842.49926.07. PMID 15277624.
- ↑ Pritchett AM, Morrison JF, Edwards WD, Schaff HV, Connolly HM, Espinosa RE (2002). "Valvular heart disease in patients taking pergolide". Mayo Clin Proc. 77 (12): 1280–6. doi:10.4065/77.12.1280. PMID 12479512.